(Q22242332)

7 February 2023

M. B. de Koning

1

0 references

O. J. N. Bloemen

2

O J N

Bloemen

1 reference

7 February 2023

T. A. M. J. van Amelsvoort

3

T A M J

van Amelsvoort

1 reference

7 February 2023

H. E. Becker

4

H E

Becker

1 reference

7 February 2023

D. H. Nieman

5

D H

Nieman

1 reference

7 February 2023

D. H. Linszen

7

D H

Linszen

1 reference

Acta Psychiatrica Scandinavica

7 February 2023

language of work or name

English

0 references

publication date

June 2009

0 references

published in

0 references

volume

119

0 references

issue

6

0 references

page(s)

426-442

0 references

cites work

The prodromal phase of first-episode psychosis: past and current conceptualizations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

Early intervention for first episodes of schizophrenia: a preliminary exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Diagnosing schizophrenia in the initial prodromal phase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Early Intervention for psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

The New York high risk project to the Hillside recognition and prevention (RAP) program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

When and how does schizophrenia produce social deficits?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Early detection and secondary prevention of psychosis: facts and visions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Association between psychotic experiences and depression in a clinical sample over 6 months.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Can antidepressants prevent psychosis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Treatment of the schizophrenia prodrome: is it presently ethical?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

WC2H A RANDOMISED CONTROLLED MULTICENTER TRIAL OF COGNITIVE BEHAVIOUR THERAPY IN THE EARLY INITIAL PRODROMAL STATE OF PSYCHOSIS

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Symptom assessment in schizophrenic prodromal states

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Early detection and intervention in first-episode schizophrenia: a critical review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Institute of Medicine report on prevention of mental disorders. Summary and commentary

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

The schizophrenia prodrome revisited: a neurodevelopmental perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Prospective investigations of the prodromal state of schizophrenia: review of studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Neuroprotection in emerging psychotic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Prognostic factors for progression to psychosis in high risk youth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Preventing schizophrenia and psychotic behaviour: definitions and methodological issues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Early detection and intervention in psychosis: an ethical paradigm shift.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

International clinical practice guidelines for early psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Prediction of psychosis: setting the stage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2009.01372.X

7 January 2021

10.1111/J.1600-0447.2009.01372.X

Identifiers

DOI

0 references